Biotech
- All
- News
- Videos
- Photos
-
Vivek Ramaswamy Set To Enter Ohio Governor Race, Month After Quitting DOGE
Biotech entrepreneur Vivek Ramaswamy, who left President Donald Trump's Department of Government Efficiency (DOGE) last month, is expected to declare his candidacy for governor of Ohio on Monday.
-
How Trumps DOGE Co-Head Vivek Ramaswamy Built A Billion-Dollar Empire
Mr Ramaswamy, the 39-year-old biotech investor and "anti-woke" advocate, has built a billion-dollar fortune through his drug-development company, Roivant Sciences, which went public in 2021.
-
"Against Bureaucracy Back Then Too": Vivek Ramaswamy Reacts To Viral Speech
Vivek Ramaswamy on Wednesday reacted to his high school graduation speech video that is doing rounds on social media.
-
Who Is Vivek Ramaswamy, The Biotech Entrepreneur Now Part Of Trump 2.0
Donald Trump announced that biotech investor Vivek Ramaswamy, who ended his Presidential bid in January 2024, will work closely with Mr Musk on this initiative.
-
Nvidia-Backed AI Firm Unveils Drug Discovery "Breakthrough"
Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to develop new drugs.
-
Bharat Biotech Unveils Next-Gen Oral Cholera Vaccine To Address Global Health Gaps
HILLCHOL (BBV131), a novel single-strain vaccine is to be administered orally on day 0 and day 14. It is suitable for babies older than one year.
-
Bharat Biotech Launches Oral Cholera Vaccine After Successful Phase 3 Trial
Bharat Biotech International Ltd on Tuesday announced the launch of Hillchol, a novel single-strain oral cholera vaccine.
-
Vivek Ramaswamy Accuses Kamala Harris Of Leaning Into 'Identity Politics'
The 38-year-old Indian-American biotech entrepreneur drew a comparison between Harris' heritage and his own to share his views on the subject.
-
"Would Strongly Consider": Vivek Ramaswamy Eyes Trump Veep Pick's Senate Seat
Vivek Ramaswamy, the India-descent biotech entrepreneur, has thrown his hat into the ring for the US Senate seat that will fall vacant if former President Donald Trump wins the presidential polls, taking away its current occupant J.D. Vance, the Repu
-
Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent
Bharat Biotech has added the Indian Council of Medical Research (ICMR) as co-owner of the Covid-19 vaccine patent.
-
"Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins
Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health, the Hyderabad-based pharma company said on Friday.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
Over 30% Covaxin Takers Suffered Health Issues After A Year, Claims Study
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow-up study conducted at BHU.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
Vivek Ramaswamy Set To Enter Ohio Governor Race, Month After Quitting DOGE
Biotech entrepreneur Vivek Ramaswamy, who left President Donald Trump's Department of Government Efficiency (DOGE) last month, is expected to declare his candidacy for governor of Ohio on Monday.
-
How Trumps DOGE Co-Head Vivek Ramaswamy Built A Billion-Dollar Empire
Mr Ramaswamy, the 39-year-old biotech investor and "anti-woke" advocate, has built a billion-dollar fortune through his drug-development company, Roivant Sciences, which went public in 2021.
-
"Against Bureaucracy Back Then Too": Vivek Ramaswamy Reacts To Viral Speech
Vivek Ramaswamy on Wednesday reacted to his high school graduation speech video that is doing rounds on social media.
-
Who Is Vivek Ramaswamy, The Biotech Entrepreneur Now Part Of Trump 2.0
Donald Trump announced that biotech investor Vivek Ramaswamy, who ended his Presidential bid in January 2024, will work closely with Mr Musk on this initiative.
-
Nvidia-Backed AI Firm Unveils Drug Discovery "Breakthrough"
Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to develop new drugs.
-
Bharat Biotech Unveils Next-Gen Oral Cholera Vaccine To Address Global Health Gaps
HILLCHOL (BBV131), a novel single-strain vaccine is to be administered orally on day 0 and day 14. It is suitable for babies older than one year.
-
Bharat Biotech Launches Oral Cholera Vaccine After Successful Phase 3 Trial
Bharat Biotech International Ltd on Tuesday announced the launch of Hillchol, a novel single-strain oral cholera vaccine.
-
Vivek Ramaswamy Accuses Kamala Harris Of Leaning Into 'Identity Politics'
The 38-year-old Indian-American biotech entrepreneur drew a comparison between Harris' heritage and his own to share his views on the subject.
-
"Would Strongly Consider": Vivek Ramaswamy Eyes Trump Veep Pick's Senate Seat
Vivek Ramaswamy, the India-descent biotech entrepreneur, has thrown his hat into the ring for the US Senate seat that will fall vacant if former President Donald Trump wins the presidential polls, taking away its current occupant J.D. Vance, the Repu
-
Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent
Bharat Biotech has added the Indian Council of Medical Research (ICMR) as co-owner of the Covid-19 vaccine patent.
-
"Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins
Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health, the Hyderabad-based pharma company said on Friday.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
Over 30% Covaxin Takers Suffered Health Issues After A Year, Claims Study
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow-up study conducted at BHU.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
